Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Dada Nexus Posts Downbeat Results, Joins GDS Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Author: Avi Kapoor | March 26, 2024 04:54am

U.S. stock futures were higher this morning, with the Nasdaq futures gaining by around 70 points on Tuesday.

Shares of Dada Nexus Limited (NASDAQ:DADA) shares fell sharply in today's pre-market trading after the company reported downbeat fourth-quarter results.

The company’s board authorized share repurchase program of up to $40 million of American Depository Shares for two-year period through March 2026.

Dada Nexus shares dipped 9.1% to $2.30 in pre-market trading.

Here are some big stocks recording losses in today’s pre-market trading session.

  • GDS Holdings Limited (NASDAQ:GDS) fell 6.1% to $7.86 in pre-market trading. GDS Holdings is expected to report its fourth quarter and full year 2023 unaudited financial results today.
  • Star Bulk Carriers Corp. (NASDAQ:SBLK) shares declined 4.4% to $23.30 in pre-market trading.
  • FinVolution Group (NYSE:FINV) fell 3.9% to $4.74 in pre-market trading. FinVolution, last week, posted downbeat quarterly sales.
  • M&T Bank Corporation (NYSE:MTB) declined 3.7% to $137.00 in pre-market trading. M&T Bank is expected to report its first quarter 2024 earnings on Monday, April 15, 2024.
  • Tilray Brands, Inc. (NASDAQ:TLRY) fell 3.3% to $2.08 in pre-market trading after falling around 7% on Monday. Germany approved the legalization of cannabis for adult use.
  • MINISO Group Holding Limited (NYSE:MNSO) fell 2.6% to $20.12 in pre-market trading. MINISO Group recently reported better-than-expected second-quarter financial results.

 

Now Read This: Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'

Don’t forget to check out our premarket coverage here

Posted In: DADA FINV GDS MNSO MTB SBLK TLRY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist